Evaluated doses of YUTREPIA™ (treprostinil) inhalation powder from 26.5 mcg to 212 mcg which are comparable to 3 to 24 breaths of nebulized Tyvaso® per session Achieved therapeutic levels by Month 2 and continued to titrate to higher levels for approximately […]